Trials / Completed
CompletedNCT05344690
SLMAP and EPO Genetic Polymorphism in Diabetic Retinopathy
Evaluation of the Relationship Between SLMAP and EPO Genetic Polymorphism and the Risk of Diabetic Retinopathy in Egyptian Diabetic Patients: A Case-Control Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 180 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
A case-control study to assess the association between the risk of diabetic retinopathy in Egyptians and genetic polymorphism of both EPO and SLMAP genes.
Detailed description
Traditional environmental risk factors, such as glycemic control and duration of diabetes, failed to fully explain why some individuals remain protected while others progress to severe diabetic retinopathy. Several studies suggest variations in diabetic retinopathy prevalence depending on racial background and genetic polymorphism.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | SLMAP and EPO genetic polymorphism | Presence of EPO gene SNP rs551238 and SLMAP rs17058639 gene polymorphisms |
Timeline
- Start date
- 2022-05-20
- Primary completion
- 2023-04-30
- Completion
- 2023-06-30
- First posted
- 2022-04-25
- Last updated
- 2024-02-07
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05344690. Inclusion in this directory is not an endorsement.